M. R.E. Aly et al. / Carbohydrate Research 316 (1999) 121–132
129
(b) From 22. Compound 22 (0.169 g, 0.102
mmol) was treated as described for 14 to yield
15 (0.116 g, 71%).
residue was purified by flash chromatography
(1:1 petroleum ether–EtOAc) to yield 14
(0.118 g, 75%) as an oil; TLC (1:1 petroleum
ether–EtOAc): Rf 0.11. A mixture of the
aforementioned oil (0.118 g, 0.075 mmol) and
NaOH (0.17 g, 4.25 mmol) in a dioxane–wa-
ter mixture (5:0.5, 5.5 mL) was stirred at rt.
After 24 h, the pH of the solution was ad-
justed and kept at 5 by N HCl. After 24 h, the
solution was neutralized with K2CO3 and
dried under reduced pressure in the presence
of ethanolamine (0.2 mL). The residue was
treated with Ac2O (4 mL) and pyridine (8 mL)
and stirred at rt. After 15 h, the solution was
worked up as described for 10. The residue
was purified by flash chromatography (1:1
petroleum ether–EtOAc) and the un-reacted
material was separated and deprotected again
to yield 15 (0.091 g, 76%) as a colorless oil.
TLC (1:1 petroleum ether–EtOAc): Rf 0.09;
(2,3,4,6-Tetra-O-acetyl-i-
osyl)-(13)-(2-acetamido-2-deoxy-4,6-di-O-
acetyl-i- -glucopyranosyl)-(13)-(2,4,6-tri-
O-acetyl-i- -galactopyranosyl)-(14)-1,2,3,-
6-tetra-O-acetyl-h/i- -glucopyranose (16).—
D
-galactopyran-
D
D
D
According to the procedure described for the
preparation of 11, compound 15 (0.111 g, 0.07
mmol) was dissolved in 1:1:1 AcOH–MeOH–
dioxane (4.5 mL) and hydrogenolized in the
presence of Pd/C (10% Pd, 0.1 g) at rt for 48
h, then worked up and the residue was acetyl-
ated. The residue was purified by MPLC
(1.5:1 toluene–acetone) to yield 16 (0.075 g,
86%) as an amorphous mass in the ratio of
a:b 1:2. TLC (1.5:1 toluene–acetone): Rf 0.18;
1H NMR (600 MHz, CDCl3): l 6.23 (d, 0.33
H, J1,2 3.5 Hz, H-1aa), 5.65–5.63 (m, 1.7 H,
NH, H-1ab), 5.41 (t, 0.3 H, J2,3=J3,4 9.8 Hz,
H-3aa), 5.32–5.31 (m, 2 H, H-4b, H-4d), 5.20
(t, 0.7 H, H-3ab), 5.11 (t, 1 H, H-1c), 5.02–
4.91 (m, 5 H, H-4c, H-3d, H-2aa, H-2b, H-2d,
H-2ab), 4.54 (t, 1 H, J2,3 =J3,4 9.8 Hz, H-3c),
4.44–4.38 (m, 3 H, H-6%aa, H-6%ab, H-6%c, H-
1d), 4.33, 4.32 (2 d, 1 H, J1,2 7.8 Hz, H-1b),
4.14 (dd, 1 H, Jgem 12.1, J5,6 2.9 Hz, H-6aa,
H-6ab), 4.07–4.01 (m, 4 H, H-6b, H-6%b, H-
6d, H-6%d), 3.98–3.96 (m, 1.3 H, H-5aa, H-6c),
3.82 (t, 1 H, H-5d), 3.77–3.73 (m, 3.7 H,
H-3b, H-5ab, H-5b, H-4aa, H-4ab), 3.59 (br.d,
1 H, H-5c), 2.80 (br.t, 1 H, H-2c), 2.16–1.94
1
[h]D −12.0° (c 0.15, CHCl3); H NMR (600
MHz, CDCl3): l 7.40–7.10 (m, 35 H, 7 Ph),
5.33 (br.s, 1 H, H-4d), 4.99–4.84 (m, 9 H,
NH, H-4c, H-1c, H-3d, H-2d, 2.5 CH2Ph),
4.73 (d, 1 H, Jgem 10.9 Hz, CHHPh), 4.69 (d,
1 H, Jgem 10.5 Hz, CHHPh), 4.63–4.57 (m, 3
H, 1.5 CH2Ph), 4.50 (d, 1 H, Jgem 11.7 Hz,
CHHPh), 4.44–4.40 (m, 3 H, H-1b, H-1a,
CHHPh), 4.34–4.33 (m, 2 H, H-1d, CHHPh),
4.21–4.15 (m, 5 H, H-3c, H-6%d, H-6c, H-6%c,
CHHPh), 4.07 (m, 1 H, H-6d), 3.98 (m, 1 H,
H-4a), 3.92 (m, 1 H, H-4b), 3.83 (m, 1 H,
H-5d), 3.76–3.74 (m, 2 H, H-5c, H-6%a), 3.67–
3.66 (m, 2 H, H-6a, H-2b), 3.54–3.45 (m, 5 H,
H-2c, H-2a, H-6%b, H-3a, H-3b), 3.40 (m, 1 H,
H-5b), 3.36 (m, 1 H, H-6b), 3.28 (m, 1 H,
H-5a), 2.13, 2.10, 2.05, 1.99, 1.95, 1.52 (6 s, 21
H, 7 CH3CO). 13C NMR (150.9 MHz,
CDCl3): l 102.80 (C-1a, C-1b), 101.20 (C-1c),
101.10 (C-1d), 83.10 (C-3a), 82.10 (C-2a, C-
3b), 80.70 (C-2b), 77.10 (C-3c), 76.70 (C-4a),
76.40 (C-4b), 75.50 (C-5a, CH2Ph), 75.40
(CH2Ph), 75.20 (CH2Ph), 75.10 (CH2Ph),
73.70 (2 CH2Ph), 73.60 (C-5b), 72.10 (C-5c),
71.30 (C-3d, CH2Ph), 70.80 (C-5d), 69.80 (C-
4c), 69.40 (C-2d), 68.60 (C-6a), 68.40 (C-6b),
67.20 (C-4d), 63.00 (C-6c), 61.40 (C-6d), 57.40
(C-2c). FABMS (positive mode, NBOH/NaI-
matrix): m/z 1613 [MNa+]. Anal. Calcd for
C87H99NO27 (1590.66): C, 65.68; H, 6.27; N,
0.88. Found: C, 65.77; H, 6.58; N, 0.71.
13
(several s, 42 H, 14 CH3CO). C NMR (150.9
MHz, CDCl3): l 101.30, 100.90 (C-1b), 101.00
(C-1d), 99.00 (C-1c), 91.90 (C-1ab), 89.30 (C-
1aa), 76.50 (C-3b), 76.30 (C-3c), 75.50 (C-
4aa), 75.30 (C-4ab), 74.00 (C-5ab), 72.70
(C-3ab), 72.20, 71.60 (C-5c), 71.40 (C-3d),
71.20 (C-2aa) 71.10 (C-5aa), 70.90 (C-5d),
70.70 (C-2ab), 69.90 (C-2d), 69.70 (C-3aa, C-
2b), 69.50 (C-4d), 69.20 (C-4c), 67.20 (C-4b),
62.00 (C-6a), 61.80 (C-6b), 61.70 (C-6c), 61.20
(C-6d), 59.30 (C-2c). MALDIMS (positive
mode, DHB/THT-matrix): m/z 1278 [MNa+].
Anal. Calcd for C52H71NO34 (1254.09): C,
49.79; H, 5.70; N, 1.11. Found: C, 49.85; H,
6.23; N, 1.08.
i-
2 - deoxy - i -
galactopyranosyl-(14)-
D
-Galactopyranosyl-(13)-2-acetamido-
- glucopyranosyl - (13) -i -
-glucopyranose (1).
D
D
-
D